Skip to main content
Erschienen in: Surgery Today 4/2018

01.04.2018 | Original Article

Oxidized regenerated cellulose induces pleural thickening in patients with pneumothorax: possible involvement of the mesothelial–mesenchymal transition

verfasst von: Hiroki Ebana, Takuo Hayashi, Keiko Mitani, Etsuko Kobayashi, Toshio Kumasaka, Teruaki Mizobuchi, Masatoshi Kurihara, Fumiyuki Takahashi, Kazuhisa Takahashi, Kuniaki Seyama

Erschienen in: Surgery Today | Ausgabe 4/2018

Einloggen, um Zugang zu erhalten

Abstract

Purpose

The pleural covering technique, i.e., wrapping a part of or the entire surface of the lung with oxidized regenerative cellulose (ORC), reinforces visceral pleura through pleural thickening for patients with pneumothorax and cystic lung diseases. However, it remains undetermined how ORC induces pleural thickening.

Methods

A histopathological examination was performed for lung specimens from patients who had recurrent pneumothoraces after pleural covering and re-operation (n = 5). To evaluate the influence of ORC on the pleura in vitro, we used MeT-5A cells (a human pleural mesothelial cell line).

Results

Pleural thickening was confirmed in all lung specimens examined. Three months after covering, the thickened pleura showed inflammatory cell infiltration, proliferation of myofibroblasts, and expression of fibronectin and TGF-β. However, after 1 year, those findings virtually disappeared, and the thickened pleura was composed mainly of abundant collagen. When MeT-5A cells were cultured in ORC-immersed medium, their morphology changed from a cobblestone to spindle-shaped appearance. The expression of E-cadherin decreased, whereas that of N-cadherin, α-smooth muscle actin, and fibronectin increased, suggesting mesothelial–mesenchymal transition (Meso–MT).

Conclusions

Our results suggest that Meso–MT may be involved as a mechanism of pleural thickening induced by pleural covering with ORC.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Lee S, Kim HR, Cho S, Huh DM, Lee EB, Ryu KM, et al. Staple line coverage after bullectomy for primary spontaneous pneumothorax: a randomized trial. Ann Thorac Surg. 2014;98:2005–11.CrossRefPubMed Lee S, Kim HR, Cho S, Huh DM, Lee EB, Ryu KM, et al. Staple line coverage after bullectomy for primary spontaneous pneumothorax: a randomized trial. Ann Thorac Surg. 2014;98:2005–11.CrossRefPubMed
2.
Zurück zum Zitat Kurihara M, Kataoka H, Ishikawa A, Endo R. Latest treatments for spontaneous pneumothorax. Gen Thorac Cardiovasc Surg. 2010;58:113–9.CrossRefPubMed Kurihara M, Kataoka H, Ishikawa A, Endo R. Latest treatments for spontaneous pneumothorax. Gen Thorac Cardiovasc Surg. 2010;58:113–9.CrossRefPubMed
3.
Zurück zum Zitat Kurihara M, Mizobuchi T, Kataoka H, Sato T, Kumasaka T, Ebana H, et al. A total pleural covering for lymphangioleiomyomatosis prevents pneumothorax recurrence. PLoS ONE. 2016;11:e0163637.CrossRefPubMedPubMedCentral Kurihara M, Mizobuchi T, Kataoka H, Sato T, Kumasaka T, Ebana H, et al. A total pleural covering for lymphangioleiomyomatosis prevents pneumothorax recurrence. PLoS ONE. 2016;11:e0163637.CrossRefPubMedPubMedCentral
4.
Zurück zum Zitat Noda M, Okada Y, Maeda S, Sado T, Sakurada A, Hoshikawa Y, et al. An experience with the modified total pleural covering technique in a patient with bilateral intractable pneumothorax secondary to lymphangioleiomyomatosis. Ann Thorac Cardiovasc Surg. 2010;16:439–41.PubMed Noda M, Okada Y, Maeda S, Sado T, Sakurada A, Hoshikawa Y, et al. An experience with the modified total pleural covering technique in a patient with bilateral intractable pneumothorax secondary to lymphangioleiomyomatosis. Ann Thorac Cardiovasc Surg. 2010;16:439–41.PubMed
5.
Zurück zum Zitat Noda M, Okada Y, Maeda S, Sado T, Sakurada A, Hoshikawa Y, et al. A total pleural covering technique in patients with intractable bilateral secondary spontaneous pneumothorax: report of five cases. Surg Today. 2011;41:1414–7.CrossRefPubMed Noda M, Okada Y, Maeda S, Sado T, Sakurada A, Hoshikawa Y, et al. A total pleural covering technique in patients with intractable bilateral secondary spontaneous pneumothorax: report of five cases. Surg Today. 2011;41:1414–7.CrossRefPubMed
6.
Zurück zum Zitat Kusu T, Nakagiri T, Minami M, Shintani Y, Kadota Y, Inoue M, et al. Null allele alpha-1 antitrypsin deficiency: case report of the total pleural covering technique for disease-associated pneumothorax. Gen Thorac Cardiovasc Surg. 2012;60:452–5.CrossRefPubMed Kusu T, Nakagiri T, Minami M, Shintani Y, Kadota Y, Inoue M, et al. Null allele alpha-1 antitrypsin deficiency: case report of the total pleural covering technique for disease-associated pneumothorax. Gen Thorac Cardiovasc Surg. 2012;60:452–5.CrossRefPubMed
7.
Zurück zum Zitat Ebana H, Otsuji M, Mizobuchi T, Kurihara M, Takahashi K, Seyama K. Pleural covering application for recurrent pneumothorax in a patient with Birt–Hogg–Dube syndrome. Ann Thorac Cardiovasc Surg. 2016;22(3):189–92. doi:10.5761/atcs.cr.15-00228.CrossRefPubMed Ebana H, Otsuji M, Mizobuchi T, Kurihara M, Takahashi K, Seyama K. Pleural covering application for recurrent pneumothorax in a patient with Birt–Hogg–Dube syndrome. Ann Thorac Cardiovasc Surg. 2016;22(3):189–92. doi:10.​5761/​atcs.​cr.​15-00228.CrossRefPubMed
8.
Zurück zum Zitat Kadota Y, Fukui E, Kitahara N, Okura E, Ohta M. Total pleural covering technique for intractable pneumothorax in patient with Ehlers–Danlos syndrome. Gen Thorac Cardiovasc Surg. 2016;64:425–8.CrossRefPubMed Kadota Y, Fukui E, Kitahara N, Okura E, Ohta M. Total pleural covering technique for intractable pneumothorax in patient with Ehlers–Danlos syndrome. Gen Thorac Cardiovasc Surg. 2016;64:425–8.CrossRefPubMed
9.
Zurück zum Zitat Lebendiger A, Gitlitz GF, Hurwitt ES, Lord GH, Henderson J. Laboratory and clinical evaluation of a new absorbable hemostatic material prepared from oxidized regenerated cellulose. Surg Forum. 1960;10:440–3.PubMed Lebendiger A, Gitlitz GF, Hurwitt ES, Lord GH, Henderson J. Laboratory and clinical evaluation of a new absorbable hemostatic material prepared from oxidized regenerated cellulose. Surg Forum. 1960;10:440–3.PubMed
11.
Zurück zum Zitat Haynes J, Srivastava J, Madson N, Wittmann T, Barber DL. Dynamic actin remodeling during epithelial–mesenchymal transition depends on increased moesin expression. Mol Biol Cell. 2011;22:4750–64.CrossRefPubMedPubMedCentral Haynes J, Srivastava J, Madson N, Wittmann T, Barber DL. Dynamic actin remodeling during epithelial–mesenchymal transition depends on increased moesin expression. Mol Biol Cell. 2011;22:4750–64.CrossRefPubMedPubMedCentral
12.
Zurück zum Zitat Wu TH, Chiou YW, Chiu WT, Tang MJ, Chen CH, Yeh ML. The F-actin and adherence-dependent mechanical differentiation of normal epithelial cells after TGF-beta1-induced EMT (tEMT) using a microplate measurement system. Biomed Microdevice. 2014;16:465–78.CrossRef Wu TH, Chiou YW, Chiu WT, Tang MJ, Chen CH, Yeh ML. The F-actin and adherence-dependent mechanical differentiation of normal epithelial cells after TGF-beta1-induced EMT (tEMT) using a microplate measurement system. Biomed Microdevice. 2014;16:465–78.CrossRef
13.
Zurück zum Zitat Chen LJ, Ye H, Zhang Q, Li FZ, Song LJ, Yang J, et al. Bleomycin induced epithelial–mesenchymal transition (EMT) in pleural mesothelial cells. Toxicol Appl Pharmacol. 2015;283:75–82.CrossRefPubMed Chen LJ, Ye H, Zhang Q, Li FZ, Song LJ, Yang J, et al. Bleomycin induced epithelial–mesenchymal transition (EMT) in pleural mesothelial cells. Toxicol Appl Pharmacol. 2015;283:75–82.CrossRefPubMed
14.
Zurück zum Zitat Owens S, Jeffers A, Boren J, Tsukasaki Y, Koenig K, Ikebe M, et al. Mesomesenchymal transition of pleural mesothelial cells is PI3K and NFkappaB-dependent. Am J Physiol Lung Cell Mol Physiol. 2015. doi:10.1152/ajplung.00396.2014. Owens S, Jeffers A, Boren J, Tsukasaki Y, Koenig K, Ikebe M, et al. Mesomesenchymal transition of pleural mesothelial cells is PI3K and NFkappaB-dependent. Am J Physiol Lung Cell Mol Physiol. 2015. doi:10.​1152/​ajplung.​00396.​2014.
16.
Zurück zum Zitat Thiery JP, Acloque H, Huang RY, Nieto MA. Epithelial–mesenchymal transitions in development and disease. Cell. 2009;139:871–90.CrossRefPubMed Thiery JP, Acloque H, Huang RY, Nieto MA. Epithelial–mesenchymal transitions in development and disease. Cell. 2009;139:871–90.CrossRefPubMed
17.
Zurück zum Zitat Yanez-Mo M, Lara-Pezzi E, Selgas R, Ramirez-Huesca M, Dominguez-Jimenez C, Jimenez-Heffernan JA, et al. Peritoneal dialysis and epithelial-to-mesenchymal transition of mesothelial cells. N Engl J Med. 2003;348:403–13.CrossRefPubMed Yanez-Mo M, Lara-Pezzi E, Selgas R, Ramirez-Huesca M, Dominguez-Jimenez C, Jimenez-Heffernan JA, et al. Peritoneal dialysis and epithelial-to-mesenchymal transition of mesothelial cells. N Engl J Med. 2003;348:403–13.CrossRefPubMed
18.
Zurück zum Zitat Li Y, Wang J, Asahina K. Mesothelial cells give rise to hepatic stellate cells and myofibroblasts via mesothelial–mesenchymal transition in liver injury. Proc Natl Acad Sci USA. 2013;110:2324–9.CrossRefPubMedPubMedCentral Li Y, Wang J, Asahina K. Mesothelial cells give rise to hepatic stellate cells and myofibroblasts via mesothelial–mesenchymal transition in liver injury. Proc Natl Acad Sci USA. 2013;110:2324–9.CrossRefPubMedPubMedCentral
19.
Zurück zum Zitat Suzuki A, Maeda T, Baba Y, Shimamura K, Kato Y. Acidic extracellular pH promotes epithelial mesenchymal transition in Lewis lung carcinoma model. Cancer Cell Int. 2014;14:129.CrossRefPubMedPubMedCentral Suzuki A, Maeda T, Baba Y, Shimamura K, Kato Y. Acidic extracellular pH promotes epithelial mesenchymal transition in Lewis lung carcinoma model. Cancer Cell Int. 2014;14:129.CrossRefPubMedPubMedCentral
20.
Zurück zum Zitat Itoigawa Y, Harada N, Harada S, Katsura Y, Makino F, Ito J, et al. TWEAK enhances TGF-beta-induced epithelial–mesenchymal transition in human bronchial epithelial cells. Respir Res. 2015;16:48.CrossRefPubMedPubMedCentral Itoigawa Y, Harada N, Harada S, Katsura Y, Makino F, Ito J, et al. TWEAK enhances TGF-beta-induced epithelial–mesenchymal transition in human bronchial epithelial cells. Respir Res. 2015;16:48.CrossRefPubMedPubMedCentral
21.
Zurück zum Zitat Takeuchi H, Kitade M, Kikuchi I, Shimanuki H, Kumakiri J, Takeda S. Influencing factors of adhesion development and the efficacy of adhesion-preventing agents in patients undergoing laparoscopic myomectomy as evaluated by a second-look laparoscopy. Fertil Steril. 2008;89:1247–53.CrossRefPubMed Takeuchi H, Kitade M, Kikuchi I, Shimanuki H, Kumakiri J, Takeda S. Influencing factors of adhesion development and the efficacy of adhesion-preventing agents in patients undergoing laparoscopic myomectomy as evaluated by a second-look laparoscopy. Fertil Steril. 2008;89:1247–53.CrossRefPubMed
22.
Zurück zum Zitat Wiseman DM, Trout JR, Franklin RR, Diamond MP. Metaanalysis of the safety and efficacy of an adhesion barrier (Interceed TC7) in laparotomy. J Reprod Med. 1999;44:325–31.PubMed Wiseman DM, Trout JR, Franklin RR, Diamond MP. Metaanalysis of the safety and efficacy of an adhesion barrier (Interceed TC7) in laparotomy. J Reprod Med. 1999;44:325–31.PubMed
23.
Zurück zum Zitat ten Broek RP, Stommel MW, Strik C, van Laarhoven CJ, Keus F, van Goor H. Benefits and harms of adhesion barriers for abdominal surgery: a systematic review and meta-analysis. Lancet. 2014;383:48–59.CrossRefPubMed ten Broek RP, Stommel MW, Strik C, van Laarhoven CJ, Keus F, van Goor H. Benefits and harms of adhesion barriers for abdominal surgery: a systematic review and meta-analysis. Lancet. 2014;383:48–59.CrossRefPubMed
24.
Zurück zum Zitat Laurens N, Koolwijk P, de Maat MP. Fibrin structure and wound healing. J Thromb Haemost JTH. 2006;4:932–9.CrossRefPubMed Laurens N, Koolwijk P, de Maat MP. Fibrin structure and wound healing. J Thromb Haemost JTH. 2006;4:932–9.CrossRefPubMed
Metadaten
Titel
Oxidized regenerated cellulose induces pleural thickening in patients with pneumothorax: possible involvement of the mesothelial–mesenchymal transition
verfasst von
Hiroki Ebana
Takuo Hayashi
Keiko Mitani
Etsuko Kobayashi
Toshio Kumasaka
Teruaki Mizobuchi
Masatoshi Kurihara
Fumiyuki Takahashi
Kazuhisa Takahashi
Kuniaki Seyama
Publikationsdatum
01.04.2018
Verlag
Springer Singapore
Erschienen in
Surgery Today / Ausgabe 4/2018
Print ISSN: 0941-1291
Elektronische ISSN: 1436-2813
DOI
https://doi.org/10.1007/s00595-017-1597-4

Weitere Artikel der Ausgabe 4/2018

Surgery Today 4/2018 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.